Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
Inogen, Inc (INGN)
Last inogen, inc earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.inogen.com
Company Research
Source: Business Wire
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device, expanding the company’s ability to market and meet the various needs of patients with chronic respiratory diseases in the U.S.SIMEOX 200 is the next-generation of the original Simeox (currently available in select international markets). It is intended to promote and improve bronchial drainage by enhancing mobilization of bronchial secretions via high frequency oscillatory vibrations and intermittent negative pressure to the airway during exhalation. The device is intended to be prescribed for use in patients capable of independently generating cough. SIMEOX 200 is predominantly aimed to help patients with chronic lung diseases associated with mucus hypersecretion and mucus retention
Show less
Read more
Impact Snapshot
Event Time:
INGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INGN alerts
High impacting Inogen, Inc news events
Weekly update
A roundup of the hottest topics
INGN
News
- Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance Device [Yahoo! Finance]Yahoo! Finance
- Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device [Yahoo! Finance]Yahoo! Finance
- Here's Why You Should Retain Inogen Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- Inogen, Inc. (NASDAQ:INGN) is a favorite amongst institutional investors who own 78% [Yahoo! Finance]Yahoo! Finance
- Inogen, Inc. (NASDAQ: INGN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
INGN
Earnings
- 11/7/24 - Beat
INGN
Sec Filings
- 12/30/24 - Form 8-K
- 12/3/24 - Form 4
- 12/3/24 - Form 4
- INGN's page on the SEC website